NEWS & INSIGHT

Find out what’s new in the pharmaceutical and biotech industries and how it affects you.

Insights

December 14,
2017

Teva announces $3bn cost-cutting plan

Teva to close several of its manufacturing sites and cut 25% of its workforce as part of its campaign to cut annual spending by $3B.

Read More

News

August 7,
2017

PharmaBioSource represents Shire on the sale of its Krems, Austria manufacturing facility to Merck Animal Health

MSD Animal Health, known as Merck Animal Health in the United States and Canada, today announced plans to purchase a new manufacturing facility in Krems an der Donau, Austria with the intention to expand its global vaccine manufacturing capacity. The facility, currently owned by Shire plc., was built in 2002 and will add to the company’s impressive global manufacturing capabilities.

Read Press Release

News

October 11,
2016

PharmaBioSource serves as Advisor for the Sale of Irvine Pharma Services and Avrio Biopharmaceuticals to Nitto Denko Avecia

Nitto Denko Avecia Inc. (Avecia), today announced it has entered into a definitive agreement to acquire the assets of Irvine Pharmaceutical Services (Irvine) and Avrio Biopharmaceuticals (Avrio), both located in Irvine, CA. Irvine is a leading analytical development services provider and Avrio is a premier cGMP parenteral contract manufacturing organization. Avecia will consolidate both businesses into the newly established company, Nitto Avecia Pharma Services.

Read Press Release

News

February 9,
2016

PharmaBioSource advises Sagent on the sale of its Chengdu, China injectable manufacturing operation to Nanjing King-friend Biochemical Pharmaceutical Co., Ltd

Talk To Us

Whether you’re looking to streamline your business processes, buy or sell a manufacturing facility, or expedite a merger, our expert advisors are here to make it a smooth and favorable experience for you.

Representative Clients